Operative indications for lung cancer with idiopathic pulmonary fibrosis

Thoracic and Cardiovascular Surgeon

Volumn 55, Issue 8, 2007, Pages 505-508

  Kushibe, Keiji ^a   Kawaguchi, T ^a   Takahama, M ^a   Kimura, M ^a   Tojo, T ^a   Taniguchi, S ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute respiratory distress syndrome; Idiopathic pulmonary fibrosis; Lung cancer

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DECISION MAKING; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 38149082701     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-965645     Document Type: Review

References (20)

1. King TE, Costabel U, Cordier J-F et al. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664
2. Hubbard R, Venn A, Lewis S. Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000; 161: 5-8
3. Kramer MR, Berkman N, Mintz B, Godfrey S, Saute M, Amir G. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease. Ann Thorac Surg 1998; 65: 198-202
4. Lee Y-C, Wu C-T, Hsu H-H, Huang P-M, Chang Y-L. Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients. J Thorac Cardiovasc Surg 2005; 129: 984-990
5. Kawasaki H, Kanji N, Yoshida J, Nishimura M, Nishiwaki Y. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002; 81: 33-37
6. Chiyo M, Sekine Y, Iwata T et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003; 126: 1141-1146
7. Kumar P, Goldstraw P, Yamada K et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003; 125: 1321-1327
8. Fujimoto T, Okazaki T, Matsukura T et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg 2003; 76: 1674-1679
9. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes and clinical trial co-ordination. Am J Respir Crit Care Med 1994; 149: 818-824
10. Flaherty KR, Martinez FJ. The role of pulmonary function testing in pulmonary fibrosis. Opin Pulm Med 2000; 6: 404-410
11. Kutlu CA, Williams EA, Evans TW, Pastorino U, Goldstraw P. Acute lung injury and acute respiratory distress syndrome after pulmonary resection. Ann Thorac Surg 2000; 69: 376-380
12. Ruffini E, Parola A, Papalia E et al. Frequency and mortality of acute lung injury and acute respiratory distress syndrome after resection for bronchogenic carcinoma. Eur J Cardiothorac Surg 2001; 20: 30-37
13. Licker M, de Perrot M, Spiliopoulos A et al. Risk factors for acute lung injury aftet thoracic surgery for lung cancer. Anesth Analg 2003; 97: 1558-1565
14. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114: 1653-1659
15. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: implication for oxidant stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155: 479-484
16. Montuschi P, Ciabattoni G, Paredi P et al. 8-isoprostane as a biomarker of oxidant stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158: 1524-1527
17. Kuwano K, Nakashima N, Isoshima I et al. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 2003; 21: 232-240
18. Cherniack RM, Colby TV, Flint A et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1180-1188
19. Erbes R, Schaberg T, Loddenkemper R. Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest 1997; 111: 51-57
20. Cherniack RM, Colby TV, Flint A et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144: 882-900